Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical (NYSE American: XTNT) will release first quarter 2026 financial results for the period ended March 31, 2026, before market open on Wednesday, May 13, 2026.

Rhea-AI Summary

Xtant Medical (NYSE American: XTNT) will release first quarter 2026 financial results for the period ended March 31, 2026, before market open on Wednesday, May 13, 2026. Management will host a conference call at 8:30 AM ET that day; a replay will be posted on the company's investor site.

Conference dial-ins, passcode, webcast link, and replay location are provided for investors and analysts to access the live presentation and subsequent recording.

Argus May 7 session

-1.23% close to close Open Argus

Details

News Market Reaction – XTNT

In the May 7 session, XTNT declined 1.23%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for Xtant Medical’s Q1 2026 results, with the release and call ...

Analysis

This announcement sets the timetable for Xtant Medical’s Q1 2026 results, with the release and call scheduled for May 13, 2026 at 8:30 AM ET. In the past, similar earnings date notices have been followed by modest moves, such as a 0.55% gain in March 2026. Investors may focus on how Q1 figures and any updated 2026 commentary align with the profitable 2025 trajectory and recent portfolio adjustments.

Key Figures

Quarter end date: March 31, 2026 Results release date: May 13, 2026 Conference time: 8:30 AM ET +3 more

Quarter end date

March 31, 2026

First quarter 2026 reporting period

Results release date

May 13, 2026

Q1 2026 results to be released before trading

Conference time

8:30 AM ET

Start time of Q1 2026 results call

US dial-in

888-506-0062

Domestic conference call access number

International dial-in

973-528-0011

International conference call access number

Passcode

638297

Access code for Q1 2026 results call

Previous Earnings date Reports

1 past event · Latest: Mar 25

Same Type 1 event

1. Mar 25

   Earnings date announcement

   24h Move

   +0.6%

   Set timing and access details for Q4 and full-year 2025 results call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the first quarter ended March 31, 2026, before the start of trading on Wednesday, May 13, 2026. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET on that day.

Conference Details:

Conference Date: Wednesday, May 13, 2026
Conference Time: 8:30 AM ET
Conference Dial-in: 888-506-0062
International Dial-in: 973-528-0011
Passcode: 638297
Conference Call Name: Xtant Medical First Quarter 2026 Financial Results
Webcast link: https://www.webcaster5.com/Webcast/Page/3039/53872

Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."

About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-first-quarter-2026-financial-results-on-may-13-2026-302764818.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Xtant Medical (XTNT) report Q1 2026 results and when is the conference call?

Xtant Medical will release Q1 2026 results before trading on May 13, 2026, with a conference call at 8:30 AM ET. According to the company, executives Sean Browne and Scott Neils will host the live call for investors and analysts on that date.

How can investors join the Xtant Medical (XTNT) May 13, 2026 earnings conference call?

Dial 888-506-0062 (U.S.) or 973-528-0011 (international) and use passcode 638297. According to the company, those numbers and the passcode provide live access to the May 13, 2026 8:30 AM ET call.

Where will the Xtant Medical (XTNT) webcast and replay be available after the May 13, 2026 call?

The webcast and replay will be available on the company's investor site at https://xtantmedical.com/ under "Investor info." According to the company, a replay will be posted following the live May 13, 2026 presentation.

Who will present on Xtant Medical's (XTNT) Q1 2026 earnings call on May 13, 2026?

Sean Browne, President and CEO, and Scott Neils, CFO, will host the call at 8:30 AM ET. According to the company, these executives will discuss first quarter 2026 financial results and take investor questions.

What information should investors expect from Xtant Medical's (XTNT) May 13, 2026 release?

Investors should expect the company's financial results for the quarter ended March 31, 2026 released before market open on May 13, 2026. According to the company, the accompanying call and webcast will present management commentary and allow investor Q&A.